Published in Neuropsychopharmacology on March 10, 2010
Neuroscience of behavioral and pharmacological treatments for addictions. Neuron (2011) 1.57
Reduced interhemispheric resting state functional connectivity in cocaine addiction. Biol Psychiatry (2011) 1.45
Effects of methylphenidate on resting-state functional connectivity of the mesocorticolimbic dopamine pathways in cocaine addiction. JAMA Psychiatry (2013) 1.08
Effects of chronic mild traumatic brain injury on white matter integrity in Iraq and Afghanistan war veterans. Hum Brain Mapp (2012) 1.06
Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacol Ther (2012) 1.04
Diffusion tensor imaging reveals thalamus and posterior cingulate cortex abnormalities in internet gaming addicts. J Psychiatr Res (2012) 1.02
Assessing white matter integrity as a function of abstinence duration in former cocaine-dependent individuals. Drug Alcohol Depend (2010) 0.98
Biological contributions to addictions in adolescents and adults: prevention, treatment, and policy implications. J Adolesc Health (2013) 0.91
Reduced genual corpus callosal white matter integrity in pathological gambling and its relationship to alcohol abuse or dependence. World J Biol Psychiatry (2011) 0.88
Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction. Front Psychiatry (2013) 0.88
Biomarkers for the development of new medications for cocaine dependence. Neuropsychopharmacology (2013) 0.87
Brain pathways to recovery from alcohol dependence. Alcohol (2015) 0.87
Pretreatment measures of brain structure and reward-processing brain function in cannabis dependence: an exploratory study of relationships with abstinence during behavioral treatment. Drug Alcohol Depend (2014) 0.87
Neurobiological considerations in understanding behavioral treatments for pathological gambling. Psychol Addict Behav (2013) 0.86
White matter integrity as a link in the association between motivation to abstain and treatment outcome in adolescent substance users. Psychol Addict Behav (2012) 0.85
White matter integrity and behavioral activation in healthy subjects. Hum Brain Mapp (2011) 0.84
A molecular profile of cocaine abuse includes the differential expression of genes that regulate transcription, chromatin, and dopamine cell phenotype. Neuropsychopharmacology (2014) 0.84
Neuroimaging and drug taking in primates. Psychopharmacology (Berl) (2011) 0.83
The use of brain imaging to elucidate neural circuit changes in cocaine addiction. Subst Abuse Rehabil (2012) 0.80
Forced Abstinence from Cocaine Self-Administration is Associated with DNA Methylation Changes in Myelin Genes in the Corpus Callosum: a Preliminary Study. Front Psychiatry (2012) 0.80
Altered white matter in cocaine-dependent subjects with traumatic brain injury: A diffusion tensor imaging study. Drug Alcohol Depend (2015) 0.79
Hippocampal volume mediates the relationship between measures of pre-treatment cocaine use and within-treatment cocaine abstinence. Drug Alcohol Depend (2014) 0.77
Functional connectivity during language processing in acute cocaine withdrawal: a pilot study. Neurocase (2011) 0.77
Brain white matter integrity in heroin addicts during methadone maintenance treatment is related to relapse propensity. Brain Behav (2016) 0.77
Gait and balance in treatment-naïve active alcoholics with and without a lifetime drug codependence. Alcohol Clin Exp Res (2012) 0.76
Insular activation during reward anticipation reflects duration of illness in abstinent pathological gamblers. Front Psychol (2014) 0.76
Structural imaging for addiction medicine: From neurostructure to neuroplasticity. Prog Brain Res (2015) 0.75
Shared microstructural features of behavioral and substance addictions revealed in areas of crossing fibers. Biol Psychiatry Cogn Neurosci Neuroimaging (2017) 0.75
Effect of cocaine dependence on brain connections: clinical implications. Expert Rev Neurother (2015) 0.75
New non-linear color look-up table for visualization of brain fractional anisotropy based on normative measurements - principals and first clinical use. PLoS One (2013) 0.75
PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: A double-blind randomized controlled pilot trial. Addiction (2017) 0.75
Toward biomarkers of the addicted human brain: Using neuroimaging to predict relapse and sustained abstinence in substance use disorder. Prog Neuropsychopharmacol Biol Psychiatry (2017) 0.75
The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat (1992) 29.45
Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp (2002) 25.56
Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage (2006) 23.57
The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry (2005) 12.53
Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage (2002) 11.37
The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol (2000) 7.71
Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) (1999) 7.06
A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry (2008) 6.24
Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci (2008) 5.54
Diffusion tensor imaging of the brain. Neurotherapeutics (2007) 5.37
Addiction and the brain antireward system. Annu Rev Psychol (2008) 5.17
A national evaluation of treatment outcomes for cocaine dependence. Arch Gen Psychiatry (1999) 3.77
Computer-assisted delivery of cognitive-behavioral therapy for addiction: a randomized trial of CBT4CBT. Am J Psychiatry (2008) 3.74
Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis. J Neurosci (2009) 2.75
Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend (2005) 2.66
Diffusion tensor imaging during recovery from severe traumatic brain injury and relation to clinical outcome: a longitudinal study. Brain (2007) 2.59
The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat (2001) 2.48
Neurobiology of craving, conditioned reward and relapse. Curr Opin Pharmacol (2005) 2.47
Reduced anterior corpus callosum white matter integrity is related to increased impulsivity and reduced discriminability in cocaine-dependent subjects: diffusion tensor imaging. Neuropsychopharmacology (2005) 2.23
Long-term frontal brain metabolic changes in cocaine abusers. Synapse (1992) 2.16
Evidence for plasticity in white-matter tracts of patients with chronic Broca's aphasia undergoing intense intonation-based speech therapy. Ann N Y Acad Sci (2009) 2.06
Pretreatment brain activation during stroop task is associated with outcomes in cocaine-dependent patients. Biol Psychiatry (2008) 2.04
A national 5-year follow-up of treatment outcomes for cocaine dependence. Arch Gen Psychiatry (2002) 1.99
The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction (2006) 1.99
Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol Psychiatry (2002) 1.99
Diffusion tensor imaging of time-dependent axonal and myelin degradation after corpus callosotomy in epilepsy patients. Neuroimage (2006) 1.97
The validity of self-reported cocaine use in two groups of cocaine abusers. J Consult Clin Psychol (1999) 1.84
Advances in white matter imaging: a review of in vivo magnetic resonance methodologies and their applicability to the study of development and aging. Neurosci Biobehav Rev (2006) 1.77
Diffusion tensor imaging in MDMA users and controls: association with decision making. Am J Drug Alcohol Abuse (2007) 1.62
Brain macrostructural and microstructural abnormalities in cocaine dependence. Drug Alcohol Depend (2007) 1.59
Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database Syst Rev (2007) 1.59
Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology (2007) 1.57
Pre-treatment measures of impulsivity, aggression and sensation seeking are associated with treatment outcome for African-American cocaine-dependent patients. J Addict Dis (2004) 1.43
Overview of fMRI analysis. Br J Radiol (2004) 1.40
Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics. Neuroimage (2008) 1.31
Decreased frontal white-matter integrity in abstinent methamphetamine abusers. Int J Neuropsychopharmacol (2006) 1.29
Meaningful design and contrast estimability in FMRI. Neuroimage (2006) 1.28
Diffusion tensor imaging eigenvalues: preliminary evidence for altered myelin in cocaine dependence. Psychiatry Res (2007) 1.26
Abnormal corpus callosum integrity in bipolar disorder: a diffusion tensor imaging study. Biol Psychiatry (2008) 1.24
Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging. J Neurosci (2008) 1.24
Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA (1998) 1.23
To do or not to do? The complexities of addiction, motivation, self-control, and impulsivity. Am J Psychiatry (2007) 1.21
Brain maturation may be arrested in chronic cocaine addicts. Biol Psychiatry (2002) 1.20
Diffusion tensor imaging in cocaine dependence: regional effects of cocaine on corpus callosum and effect of cocaine administration route. Drug Alcohol Depend (2009) 1.15
Cognitive control and white matter callosal microstructure in methamphetamine-dependent subjects: a diffusion tensor imaging study. Biol Psychiatry (2008) 1.13
Treatment advances for cocaine-induced ischemic stroke: focus on dihydropyridine-class calcium channel antagonists. Am J Psychiatry (2001) 1.13
Cognitive function and treatment response in a randomized clinical trial of computer-based training in cognitive-behavioral therapy. Subst Use Misuse (2011) 1.12
Cocaine addiction: diffusion tensor imaging study of the inferior frontal and anterior cingulate white matter. Psychiatry Res (2010) 1.10
Cognitive remediation in the treatment of stimulant abuse disorders: a research agenda. Exp Clin Psychopharmacol (2008) 1.06
Elevations of diffusion anisotropy are associated with hyper-acute stroke: a serial imaging study. Magn Reson Imaging (2008) 0.96
Psychosocial approaches to psychostimulant dependence: a systematic review. J Subst Abuse Treat (2006) 0.94
Relationship between treatment length and outcome in a therapeutic community. Int J Addict (1994) 0.92
Biotechnology and the treatment of addictive disorders: new opportunities. BioDrugs (2007) 0.92
Outcome predictors in cocaine dependence treatment trials. Am J Addict (2006) 0.90
Allostatic view of motivation: implications for psychopathology. Nebr Symp Motiv (2004) 0.89
Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes. Addict Behav (1997) 0.87
Illusory predictors: Generalizability of findings in cocaine treatment retention research. Addict Behav (2007) 0.82
Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry (2003) 7.11
Can food be addictive? Public health and policy implications. Addiction (2011) 6.27
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol (2010) 4.77
We don't train in vain: a dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psychol (2005) 4.71
Substance abuse and fathering: adding poppa to the research agenda. Addiction (2002) 3.94
Computer-assisted delivery of cognitive-behavioral therapy for addiction: a randomized trial of CBT4CBT. Am J Psychiatry (2008) 3.74
Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch Gen Psychiatry (2004) 3.72
Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. Drug Alcohol Depend (2006) 3.61
Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry (2006) 3.55
Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (2011) 3.42
Compulsive features in behavioural addictions: the case of pathological gambling. Addiction (2011) 3.28
Introduction to behavioral addictions. Am J Drug Alcohol Abuse (2010) 3.22
Single versus multiple drug focus in substance abuse clinical trials research. Drug Alcohol Depend (2003) 3.19
Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend (2004) 3.09
Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom? Addiction (2004) 3.06
Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol (2006) 3.02
Site matters: multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol (2007) 2.98
Meditation experience is associated with differences in default mode network activity and connectivity. Proc Natl Acad Sci U S A (2011) 2.93
Bridging the gap: a hybrid model to link efficacy and effectiveness research in substance abuse treatment. Psychiatr Serv (2003) 2.77
Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology (2009) 2.60
Mindfulness-based treatments for co-occurring depression and substance use disorders: what can we learn from the brain? Addiction (2010) 2.50
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry (2006) 2.50
Preliminary validity and reliability testing of a structured clinical interview for pathological gambling. Psychiatry Res (2004) 2.35
Community program therapist adherence and competence in motivational enhancement therapy. Drug Alcohol Depend (2008) 2.33
Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology (2006) 2.32
The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J Consult Clin Psychol (2006) 2.31
The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol (2007) 2.22
Individuals family history positive for alcoholism show functional magnetic resonance imaging differences in reward sensitivity that are related to impulsivity factors. Biol Psychiatry (2010) 2.16
Broadening our horizon: response to commentaries. Addiction (2012) 2.11
A vision of the next generation of behavioral therapies research in the addictions. Addiction (2007) 2.09
Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry (2005) 2.09
Health correlates of recreational gambling in older adults. Am J Psychiatry (2004) 2.08
Enduring effects of a computer-assisted training program for cognitive behavioral therapy: a 6-month follow-up of CBT4CBT. Drug Alcohol Depend (2008) 2.06
Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. Anal Chem (2009) 2.06
Pretreatment brain activation during stroop task is associated with outcomes in cocaine-dependent patients. Biol Psychiatry (2008) 2.04
Gender differences in the associations between past-year gambling problems and psychiatric disorders. Soc Psychiatry Psychiatr Epidemiol (2007) 2.02
Contingency management treatments: Reinforcing abstinence versus adherence with goal-related activities. J Consult Clin Psychol (2006) 1.98
Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone. Am J Psychiatry (2014) 1.93
Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. Addiction (2012) 1.93
Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis. Behav Pharmacol (2009) 1.90
Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord (2009) 1.89
A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry (2002) 1.86
Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study. Psychopharmacology (Berl) (2005) 1.84
Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Am J Psychiatry (2005) 1.82
Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology (Berl) (2011) 1.77
Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. Ann Neurol (2010) 1.77
Problematic Internet use: clinical implications. CNS Spectr (2007) 1.74
Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials. Arch Intern Med (2003) 1.74
Impulse control disorders in Parkinson disease: a multicenter case--control study. Ann Neurol (2011) 1.73
An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD. Am J Psychiatry (2009) 1.70
Mindfulness training for smoking cessation: results from a randomized controlled trial. Drug Alcohol Depend (2011) 1.68
Psychiatric correlates of gambling in adolescents and young adults grouped by age at gambling onset. Arch Gen Psychiatry (2004) 1.68
Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab Dispos (2003) 1.66
Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry (2003) 1.63
Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage I pilot study. Subst Abus (2009) 1.62
Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) (2009) 1.62
The neurobiology of substance and behavioral addictions. CNS Spectr (2006) 1.59
Neurodevelopment, impulsivity, and adolescent gambling. J Gambl Stud (2003) 1.57
Neuroscience of behavioral and pharmacological treatments for addictions. Neuron (2011) 1.57
Video-gaming among high school students: health correlates, gender differences, and problematic gaming. Pediatrics (2010) 1.56
Cognitive enhancement as a treatment for drug addictions. Neuropharmacology (2012) 1.54
Gambling: an addictive behavior with health and primary care implications. J Gen Intern Med (2002) 1.52
Gender differences in adolescent gambling. Ann Clin Psychiatry (2006) 1.51
An initial study of neural responses to monetary incentives as related to treatment outcome in cocaine dependence. Biol Psychiatry (2011) 1.50
The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol (2004) 1.50
Correspondence of motivational enhancement treatment integrity ratings among therapists, supervisors, and observers. Psychother Res (2009) 1.49
A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biol Psychiatry (2007) 1.48
A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence. J Stud Alcohol Suppl (2005) 1.47
Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint? Ann N Y Acad Sci (2010) 1.46
The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study. Psychiatry Res (2009) 1.46
Intention-to-treat meets missing data: implications of alternate strategies for analyzing clinical trials data. Drug Alcohol Depend (2002) 1.45
What is usual about "treatment-as-usual"? Data from two multisite effectiveness trials. J Subst Abuse Treat (2008) 1.45
Diminished frontostriatal activity during processing of monetary rewards and losses in pathological gambling. Biol Psychiatry (2012) 1.44
Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude. Exp Clin Psychopharmacol (2002) 1.44
Stealing among high school students: prevalence and clinical correlates. J Am Acad Psychiatry Law (2011) 1.43
Gender differences in adolescent marijuana use and associated psychosocial characteristics. J Addict Med (2011) 1.42
Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials (2011) 1.38
Assessing the role of Asp 194 in the transmembrane domains of the α-chain of the high-affinity receptor complex for immunoglobulin E in signal transduction. Mol Immunol (2010) 1.38
Compulsive aspects of impulse-control disorders. Psychiatr Clin North Am (2006) 1.37
A targeted review of the neurobiology and genetics of behavioural addictions: an emerging area of research. Can J Psychiatry (2013) 1.37
Simulated apoptosis/neurogenesis regulates learning and memory capabilities of adaptive neural networks. Neuropsychopharmacology (2004) 1.36
Reasons for dropout from drug abuse treatment: symptoms, personality, and motivation. Addict Behav (2005) 1.36
Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol (2007) 1.35